نمایش پرونده ساده آیتم

dc.contributor.authorAzimi, H
dc.contributor.authorZadeh, MG
dc.contributor.authorJaberian, M
dc.contributor.authorOmid, M
dc.date.accessioned2018-08-26T08:06:13Z
dc.date.available2018-08-26T08:06:13Z
dc.date.issued2012
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/49980
dc.description.abstractObjective: To compare efficiency of cryotherapy followed by Acnalen gel 0.1% with cryotherapy plus placebo in the treatment of AKs (Actinic Keratosis). Methodology: One hundred outpatients who had a clinical diagnosis of actinic keratoses on face or scalp with at least five lesions were enrolled in the study. Patients were randomized into two groups: cryotherapy plus placebo and cryotherapy plus Acnalen 0.1% gel for a period of 100 days. Lesion counts were assessed at baseline, and 40, 70 and 100 days after cryotherapy. Results: Mean baseline number of lesions for cryotherapy plus Acnalen gel group and cryotherapy plus placebo group were 7.54 +/- 3.66 and 7.20 +/- 3.60. In Acnalen group mean number of lesions reduced to 3.44 +/- 2.71(54.79 +/- 3.8%down arrow) and in placebo group reduced to 3.68 +/- 2.97 (48.60 +/- 4.5%down arrow) (P=0.62). Conclusions: Our results suggested that cryotherapy and Acnalen 0.1% gel during 100 days cannot be more helpful than cryotherapy alone in the treatment of clinical AKs.
dc.language.isoEnglish
dc.relation.ispartofPAKISTAN JOURNAL OF MEDICAL SCIENCES
dc.subjectActinic keratoses
dc.subjectCryotherapy
dc.subjectAcnalen 0.1% gel
dc.titleComparison of the efficacy of cryotherapy and 0.1% Acnalen gel vs. cryotherapy and placebo in the treatment of actinic keratoses
dc.typeArticle
dc.citation.volume28
dc.citation.issue1
dc.citation.spage54
dc.citation.epage57
dc.citation.indexWeb of science
dc.citation.URLhttps://pjms.com.pk/index.php/pjms/article/view/1505


فایلهای درون آیتم

Thumbnail

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم